Business Standard

Monday, December 23, 2024 | 03:03 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Biocon Share Price

Know More
BSENSE

330.60-5.35 (-1.59%)

02:55 PM, 23-Dec-2024

331.10-4.85 (-1.44%)

02:39 PM, 23-Dec-2024

BSE : 532523

NSE : BIOCON

Sector : Health care

ISIN Code : INE376G01013

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 23-Dec-2024 | 02:55 PM IST

Market Cap (₹ Cr)

39,692

Traded Value (₹ Cr)

1.81

Volume (Shares)

54,896

Face Value (₹)

5

52-Week High (₹)

395.65

52-Week High Date

17-Sep-2024

52-Week Low (₹)

239.45

52-Week Low Date

21-Dec-2023

All Time High (₹)

487.70

All Time High Date

23-Dec-2020

All Time Low (₹)

14.42

All Time Low Date

28-Nov-2008

Biocon Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

39,752

EPS - TTM (₹) [C]

11.61

P/E Ratio (X) [C]

28.52

Face Value (₹) 5
Latest Dividend (%)10.00
Latest Dividend Date 05-Jul-2024
Dividend Yield (%) 0.15
Book Value Share (₹) [C]174.85
P/B Ratio (₹) [C]1.89

Funds Owning this Stock

Research Reports

DateBrokerActionPrices(₹) Report
12-Aug-2024ICICI Securities Sell 235
18-May-2024ICICI Securities Sell 245

Stock Strength

Today's Low/High (₹)

330.05

339.60

Week Low/High (₹)

330.05

359.00

Month Low/High (₹)

322.60

382.00

Year Low/High (₹)

239.30

396.00

All time Low/High (₹)

14.42

488.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-6.38%-6.39%-3.95-3.69%
1 Month-0.03%-0.12%-0.76-0.62%
3 Month-10.61%-10.60%-7.55-8.40%
6 Month-4.20%-4.22%1.691.10%
1 Year34.48%34.43%10.4211.29%
3 Year-11.57%-11.55%36.9939.17%

Company Info

Company Information

Chairperson : Kiran Mazumdar Shaw

Non Executive Director : Ravi Mazumdar

Lead Independent Director : M Damodaran

Independent Director : Bobby Parikh

Company Sec. & Compli. Officer : Mayank Verma

Managing Director & CEO : SIDDHARTH MITTAL

Non Executive Director : Eric Vivek Mazumdar

Independent Director : Naina Lal Kidwai

Independent Director : Atul Dhawan

Independent Director : Rekha Mehrotra Menon

Independent Director : NICHOLAS ROBERT HAGGAR

Registered Office: 20th KM Hosur Road Hebbagodi, Electronic City P O,Bangalore,Karnataka-560100 Ph: 91-80-28082808

Email:co.secretary@biocon.com

URL:http://www.biocon.com

FAQs about Biocon Ltd

1. What's the Biocon Ltd share price today?
Biocon Ltd share price was Rs 330.60 at 02:55 PM IST on 23rd Dec 2024. Biocon Ltd share price was down by 1.59% from the previous closing price of Rs 335.95. Biocon Ltd share price trend:

  • Last 1 Month: Biocon Ltd share price moved down by 0.03% on BSE
  • Last 3 Months: Biocon Ltd share price moved down by 10.61% on BSE
  • Last 12 Months: Biocon Ltd share price moved up by 34.48% on BSE
  • Last 3 Years: Biocon Ltd price moved down by 11.57% on BSE


2. How can I quickly analyse the performance of the Biocon Ltd stock?
The performance of the Biocon Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 28.52
  • Price to book value ratio is 1.89
  • Dividend yield of 0.15
  • The EPS (trailing 12 months) of the Biocon Ltd stock is Rs 11.61


3. What is the market cap of Biocon Ltd?
Biocon Ltd has a market capitalisation of Rs 39,692 crore.


4. What is Biocon Ltd's 52-week high/low share price?
The Biocon Ltd’s 52-week high share price is Rs 395.65 and 52-week low share price is Rs 239.45.


5. Is the Biocon Ltd profitable?
On a consolidated basis, Biocon Ltd reported a profit of Rs 3.20 crore on a total income of Rs 598.90 crore for the quarter ended 2024. For the year ended Sep 2024, Biocon Ltd had posted a profit of Rs 27.10 crore on a total income of Rs 3,648.90 crore.


6. Which are Biocon Ltd’s peers in the Health care sector?
Biocon Ltd’s top 5 peers in the Health care sector are Abbott India, Glenmark Pharma., Ipca Labs., Biocon, Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma.


7. Who owns how much in Biocon Ltd?
Key changes to the Biocon Ltd shareholding are as follows:

  • Promoter holding in Biocon Ltd has gone up to 60.64 per cent as of Sep 2024 from 60.64 per cent as of Dec 2023.